Carisma's VP of Discovery Research, Michael Klichinsky, presents at the CAR and T cell therapies: Pioneering point of care with innovative manufacturing and commercialization strategies meeting in San Francisco, CA, June 18-20, 2019.
Carisma Therapeutics is excited to welcome Robert Petit, PhD as its Chief Scientific Officer.
Carisma's Michael Klichinsky, VP of Discovery Research, joins leaders in cell therapy to present at the CAR-T and the Rise of Cellicon Valley conference to be held May 9-10, 2019 at the University of Pennsylvania (Penn).
Carisma leadership recently spoke with BioWorld about plans for a first clinical study using the novel therapeutic modality of chimeric antigen receptor expressing macrophages, "CAR-M".
Carisma Therapeutics management will present at the William Blair 9th Annual Cancer Immunotherapy Conference and the Alliance for Regenerative Medicine Cell & Gene Investment Day on March 20-21, 2019 in New York City.
Carisma Therapeutics is presenting a scientific poster at the Keystone Symposium on Molecular and Cellular Biology dedicated to Myeloid Cells, taking place February 24-28, 2019 in Santa Fe, NM.